Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes

Blood

Volumn 97, Issue 1, 2001, Pages 114-121

  Dyall, Julie ^a   Latouche, Jean Baptiste ^a   Schnell, Stefan ^a   Sadelain, Michel ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLU PEPTIDE; HLA A2 ANTIGEN; PLASMID DNA; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VECTOR;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOTHERAPY; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0035169569     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.1.114     Document Type: Article

References (71)

1. Dendritic cells and the control of immunity
2. Dendritic cells
3. Dendritic cell vaccines for cancer immunotherapy
4. + cord blood cells under serum-free conditions
5. + cells
6. Retroviral expression of MUC-1 human tumor antigen with intact repeat structure and capacity to elicit immunity in vivo
7. + cells
8. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene
9. Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity
10. Integration of murine leukemia virus DNA depends on mitosis
11. Evidence that retroviruses integrate into post-replication host DNA
12. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
13. Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells
14. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium
15. Generation and functional characterization of mouse monocyte-derived dendritic cells
16. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus
17. HIV-1, Vpr and the cell cycle
18. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
19. Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes
20. The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphocytes
21. Potent induction of human cytotoxic T lymphocytes against viral and tumor antigens by artificial antigen-presenting cells
22. High-efficiency transformation of mammalian cells by plasmid DNA
23. A third-generation lentivirus vector with a conditional packaging system
24. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
25. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
26. Active site-directed double mutants of dihydrofolate reductase
27. Effects of retroviral vector design on expression of human adenosine deaminase in routine bone marrow transplant recipients engrafted with genetically modified cells
28. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood
29. Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability
30. + T cells
31. + helper T cells
32. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes
33. Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system
34. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
35. Alu polymerase chain reaction: A method for rapid isolation of human-specific sequences from complex DNA sources
36. The minimum peptide epitope from the influenza virus matrix protein: Extra and intracellular loading of HLA-A2
37. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes
38. In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides
39. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood
40. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2
41. Analysis of mutant HLA-A2 molecules
42. Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes
43. A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells
44. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis
45. Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells
46. Lentiviral vectors - The promise of gene therapy within reach?
47. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
48. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
49. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector
50. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
51. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1
52. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells
53. Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex
54. + cytotoxic T lymphocytes by dendritic cells
55. + cytotoxic T lymphocytes
56. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells
57. Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4
58. Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins
59. Maturation, activation and protection of dendritic cells induced by double-stranded RNA
60. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
61. Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: Implications for the clinical use of dendritic cells
62. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
63. High efficiency adenovirus-mediated gene transfer to human dendritic cells
64. Pure populations of transduced primary human cells can be produced using GFP expressing herpes virus vectors and flow cytometry
65. Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus
66. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1
67. Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors
68. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
69. Reciprocal control of T helper cell and dendritic cell differentiation
70. Dendritic cell subtypes in mouse lymphoid organs: Cross-correlation of surface markers, changes with incubations, and differences among thymus, spleen, and lymph nodes